InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.31
(
0.00%
)
US TECH 100
17,654.60
(
0.08%
)
Dow Jones
39,474.78
(
0.22%
)
Brent Oil
82.71
(
-1.48%
)
Bitcoin
60,580.92
(
-3.90%
)
Post# of 71
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

surf1944

Send PM Follow Ignore
Followers 468
Posts 26926
Boards Moderated 2
Alias Born 09/11/2006

surf1944

Re: surf1944 post# 33

Sunday, 07/10/2011 4:22:24 PM

Sunday, July 10, 2011 4:22:24 PM

Post# of 71
Gentium announces NDA submission for Defibrotide
theflyonthewall

On Wednesday July 6, 2011, 7:35 am EDT

Gentium S.p.A. announced that it has submitted a New Drug Application, NDA, to the United States Food and Drug Administration, FDA, for Defibrotide for the treatment of hepatic veno-occlusive disease, VOD, in adults and children undergoing hematopoietic stem-cell transplantation, HSCT.


surf's up......crikey



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up